Coronary Artery Bypass Graft Market Size, Share, Growth – By Product, By Method, By Surgery Type, By End Use – Global Forecast, 2024 – 2032

Coronary Artery Bypass Graft Market Size

The global coronary artery bypass graft market size was valued at USD 11.8 billion in 2023 and is estimated to grow at 7.1% CAGR from 2024 to 202. Coronary artery bypass graft (CABG) is a surgical procedure for treating coronary artery disease (CAD). The operation creates a new pathway for blood flow to the heart using a graft. This graft is typically a section of blood vessel taken from another part of the patient's body, such as the leg's saphenous vein or the chest's internal mammary artery.
 

The coronary artery bypass graft (CABG) market is experiencing significant growth driven by the increasing global prevalence of coronary heart disease. According to the World Health Organization (WHO), cardiovascular disease remains the leading cause of death worldwide, claiming approximately 17.9 million lives annually. Additionally, the rising incidence of chronic conditions, such as diabetes and pulmonary arterial hypertension, further contributes to this market expansion. Elevated blood sugar levels can damage the blood vessels supplying the heart, thereby increasing the risk of cardiovascular diseases.
 

Moreover, the expanding geriatric population plays a significant role in market growth, with the United Nations projecting that this demographic will reach 2.1 billion by 2050, effectively doubling its current size. Older individuals are more vulnerable to cardiovascular diseases due to the gradual accumulation of fat deposits on artery walls, making CABG an essential intervention for this population. In addition to the geriatric population, favourable reimbursement policies are positively influencing the CABG market, enhancing accessibility, and encouraging the adoption of surgical procedures. Together, these factors underscore the growing importance of CABG in addressing the global burden of cardiovascular diseases.
 

Coronary Artery Bypass Graft Market Trends

• Minimally invasive CABG techniques, including robotic-assisted surgeries, are gaining popularity due to shorter recovery times, reduced hospital stays, and lower risk of complications. Robotic and endoscopic-assisted CABG procedures are becoming more common among patients and surgeons for their precision and effectiveness.
   
• According to UCSF Health, minimally invasive CABG procedures have shown a significant reduction in hospital stay duration and shorter recovery time compared to traditional open-heart surgery. This trend towards less invasive techniques is likely to continue as technology advances and surgical expertise grows.
   
• Additionally, hybrid revascularization procedures, combining CABG with percutaneous coronary interventions (PCI), are emerging as an effective approach for treating complex coronary artery disease. This method allows for improved treatment of multi-vessel disease by integrating the benefits of both surgical and non-surgical techniques, resulting in better patient outcomes.
   
• Furthermore, off-pump coronary artery bypass (OPCAB), which avoids the use of a heart-lung machine, is increasingly preferred as it reduces complications associated with on-pump procedures, such as bleeding and cognitive dysfunction. OPCAB is particularly suitable for high-risk patients and offers benefits including reduced post-operative recovery time.
   

Coronary Artery Bypass Graft Market Analysis

The market is segmented into grafts, retractors, heart positioners, tissue stabilizers, and other products based on product. The grafts segment is further sub-segmented into saphenous vein grafts, internal thoracic artery grafts, and other grafts. The grafts segment was worth over USD 3.1 billion in 2023.
 

• Improvements in manufacturing techniques, including tissue engineering and 3D printing, have enabled the production of grafts that more closely resemble natural blood vessels. These advancements reduce post-surgical complications, enhance compatibility, and lower rejection rates, making coronary artery bypass grafting (CABG) more accessible and increasing demand for advanced grafts.
   
• Innovations in graft materials, such as synthetic, bioengineered, and drug-eluting grafts, are significantly improving outcomes. These new materials are more durable, biocompatible, and less prone to restenosis, reducing complications and improving patient recovery, which supports market growth.
   
• The trend toward hybrid coronary revascularization, combining CABG with percutaneous coronary intervention (PCI), is gaining prominence, particularly for complex cases. These hybrid procedures often utilize both traditional and synthetic grafts, expanding the market for grafts that accommodate these dual approaches.
   
• Therefore, the aforementioned factors are likely to sustain the demand for standard formulas in the near future.
   

Based on method, the coronary artery bypass graft market is bifurcated into traditional (on-pump) CABG and minimally invasive direct CABG. The traditional (on-pump) CABG segment dominated the market with the largest revenue share of 55.1% in 2023.
 

• The increasing global prevalence of coronary artery disease (CAD) is a key factor driving coronary artery bypass graft (CABG) procedures. Coronary heart disease (CHD) is the most prevalent form of heart disease, responsible for around 375,476 deaths annually. Additionally, approximately 805,000 people in the U.S. experience a heart attack each year, highlighting the critical need for effective treatments like traditional CABG.
   
• Additionally, sedentary lifestyles, poor dietary habits, and the rising incidence of conditions such as diabetes and hypertension contribute significantly to CAD, thereby increasing the demand for traditional CABG surgeries to enhance patient outcomes.
   
• Furthermore, traditional on-pump CABG is often the preferred choice for complex cases, particularly in multi-vessel disease scenarios where precision and control are crucial. The heart-lung machine used in on-pump CABG provides a stable, bloodless surgical field, making it advantageous for high-risk or complex patients. This factor maintains the demand for this procedure among surgeons and cardiologists.
• Therefore, the aforementioned factors are expected to significantly boost the growth of the segment over the forecast period.
   

The market is segmented into single CABG surgery, double CABG surgery, triple CABG surgery, and quadruple CABG surgery based on surgery type. The single CABG surgery segment is projected to reach USD 7.1 billion by 2032.
 

• Single CABG offers a focused approach for patients with limited artery blockage, presenting a less invasive alternative to multi-vessel bypass surgery. The increasing adoption of minimally invasive techniques, including surgical robots, is driving demand for targeted surgical interventions in coronary artery disease treatment.
   
• The expanding elderly population is a key factor driving the single CABG market. Older individuals face a higher risk of coronary artery disease and related conditions. Single CABG is often preferred for elderly patients with isolated blockages, offering a targeted intervention with a lower risk profile.
   
• The World Health Organization reports that the global population aged 60 years and older is expected to double from 1 billion in 2020 to 2.1 billion by 2050. This demographic shift is likely to increase the demand for single CABG procedures, as they offer a balance between effective treatment and reduced surgical risk for older patients.
   
• Therefore, the aforementioned factors are expected to significantly boost the growth of the segment in the coming years.
   

The market is segmented by end use into hospitals, cardiology centers, and other end users. In 2023, the hospitals segment was valued at USD 5.3 billion.
 

• Cardiovascular disease remains a leading cause of mortality globally, maintaining high demand for CABG procedures in hospitals. According to the World Health Organization (WHO), cardiovascular diseases are responsible for 31% of all deaths worldwide. This high prevalence of cardiovascular disease underscores the continued importance of CABG procedures in hospital settings.
   
• Hospitals are equipped with advanced facilities necessary for CABG procedures, including heart-lung machines, intensive care units (ICU), and specialized operating rooms. These comprehensive facilities support safe and effective CABG surgeries, making hospitals the preferred setting for these procedures.
   
• Additionally, complex cases of multi-vessel coronary artery disease (CAD) that require surgical intervention are frequently handled in hospitals. Multi-vessel disease often necessitates a controlled environment and specialized surgical expertise found in hospital settings, wherein the precision required for successful CABG can be provided.
   

The U.S. coronary artery bypass graft market was crossed USD 3.5 billion in 2023 and is expected to grow at a CAGR of 6.7% through 2032.
 

• U.S. hospitals are increasingly adopting advanced surgical techniques for coronary artery bypass grafting (CABG), including minimally invasive and robotic-assisted procedures. These advancements reduce recovery time and post-surgical complications, making CABG a more attractive and accessible option for patients, thereby increasing its demand.
   
• The rising incidence of multi-vessel disease, where blockages occur in more than one coronary artery, is leading to increased demand for CABG in the U.S. Single-vessel interventions like percutaneous coronary intervention (PCI) may be less effective for these cases, making CABG the preferred treatment for complex coronary artery disease.
   
• According to the National Institutes of Health, approximately 400,000 CABG procedures are performed annually in the U.S. This high number of procedures reflects the continued importance of CABG in treating coronary artery disease.
   
• Therefore, the aforementioned factors are expected to boost market growth in the region over the coming years.
   

The coronary artery bypass graft market in the UK is expected to experience significant growth from 2024 to 2032.
 

• The increasing prevalence of conditions such as diabetes and hypertension in the United Kingdom is contributing to a higher risk of coronary artery disease (CAD).
   
• According to Diabetes UK, an estimated 5.6 million people in the UK are living with diabetes. Similarly, hypertension affects around 26-28% of adults in England. These rising rates are leading to an increased number of patients requiring coronary artery bypass grafting (CABG) surgery to manage heart disease complications. This trend underscores the growing importance of CABG procedures in addressing the cardiovascular health challenges faced by the UK population.
   
• The National Health Service (NHS) has prioritized reducing wait times for cardiac procedures, including CABG. Through initiatives aimed at streamlining referral pathways and improving access to timely cardiac care, more patients are undergoing CABG procedures. For instance, the NHS Long Term Plan aims to increase the number of planned operations significantly by 2023/24. This focus on accessibility and reduced wait times is driving increased demand for these surgeries, potentially leading to improved outcomes for patients with severe coronary artery disease.
   
• Hence, the increasing awareness and government programs are expected to significantly boost the market growth in the region over the coming years.
   

The Japan coronary artery bypass graft market is anticipated to witness substantial growth between 2024 – 2032.
 

• In 2023, the average life expectancy in Japan was 87.14 years for women and 81.09 years for men, ranking among the highest globally according to the World Health Organization (WHO). This longevity has led to a rapidly aging population, with 29.1% of Japanese citizens aged 65 or older in 2023, as reported by the BBC.
   
• This aging population contributes to a higher incidence of age-related cardiovascular diseases. This demographic trend increases the demand for coronary artery bypass graft (CABG) surgeries, particularly for treating coronary artery disease (CAD).
   
• Additionally, advancements in surgical techniques, including minimally invasive CABG and robotic-assisted procedures, are becoming more prevalent in Japan. These innovations enhance surgical outcomes and shorten recovery periods, making CABG a more appealing option for patients and consequently driving market growth.
   
• Therefore, the following factors are expected to bolster market growth in the region over the forecast period.
   

The coronary artery bypass graft market in Saudi Arabia is expected to experience significant growth from 2024 to 2032.
 

• The Saudi government has invested substantially in healthcare infrastructure as part of its Vision 2030 initiative. These investments aim to expand healthcare facilities and services, including specialized cardiac care units, thereby increasing the country's capacity for performing CABG surgeries.
   
• Additionally, Saudi Arabia is establishing itself as a medical tourism destination, attracting patients from neighboring countries seeking high-quality healthcare services. The availability of advanced cardiac procedures, including CABG, appeals to international patients, thus expanding the market for these surgeries within the country.
   
• Therefore, the aforementioned factors are expected to boost market growth in the region over the coming years.
   

Coronary Artery Bypass Graft Market Share

The coronary artery bypass graft industry is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A key aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.
 

Coronary Artery Bypass Graft Market Companies

Some of the eminent market participants operating in the coronary artery bypass graft industry include:

• Abbott Laboratories
• AngioDynamics
• AtriCure
• B. Braun Melsungen AG
• Boston Scientific
• Cardinal Health
• CryoLife
• Edwards Lifesciences
• Johnson & Johnson
• LivaNova
• Medline Industries
• Medtronic
• Nipro Corporation
• Stryker Corporation
• Terumo Corporation

Coronary Artery Bypass Graft Industry News

• In August 2024, DePuy Synthes announced the launch of the MatrixSTERNUM Fixation System. This plate and screw fixation system was designed to stabilize and secure the front part of the chest wall following procedures such as open-heart surgery and chest surgery. This launch is anticipated to enhance DePuy Synthes' portfolio in thoracic surgical solutions.
   
• In October 2023, SS Innovations International, Inc., a developer of advanced surgical robotic technologies, launched a robotic cardiac surgery program in India featuring its flagship SSi Mantra surgical robotic system. The program aimed to revitalize robotic coronary artery bypass and intracardiac surgery in India and to train surgeons nationwide in these specialized procedures with the SSi Mantra. This launch was anticipated to strengthen SS Innovations International, Inc.'s market presence in India, drive innovation in cardiac surgery, and position the company as a leader in the expanding field of robotic surgical technologies.
   

This coronary artery bypass graft market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Grafts
  • Saphenous vein grafts
  • Internal thoracic artery grafts
  • Other grafts
• Retractors
• Heart positioners
• Tissue stabilizers
• Other products

Market, By Method

• Traditional (on-pump) CABG
• Minimally invasive direct CABG
  • Off-pump CABG
  • Keyhole CABG
  • Other minimally invasive CABG surgeries

Market, By Surgery Type

• Single CABG surgery
• Double CABG surgery
• Triple CABG surgery
• Quadruple CABG surgery

Market, By End Use

• Hospitals
• Cardiology centers
• Other end users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE